The managing director of one of Lynn biggest employers is looking ahead to a multi- million pound expansion which could create up to 200 new jobs.
Bespak is hoping to complete its first major building project for some time at the North Lynn site if planning permission is approved to construct two new manufacturing units.
Managing director Keyvan Djamarani has praised his staff and their expertise in continuing to attract new contracts.
The company has won a contract to create a nicotine inhaler with Nicoventures and is working on a second contract to produce a drug delivery device.
Mr Djamarani said it was an exciting time for the company and West Norfolk.
He said: “In some respects it is a testament to the people and the organisation we have in Lynn which effectively helps to create these opportunities.
“To potentially create up to 200 new jobs is superb.”
Bespak currently employs 580 people at its site on the North Lynn, which creates medical equipment.
The firm produces respiratory, injectable and other medical devices.
As reported in our Tuesday edition, the company has submitted a planning application to West Norfolk Council to put up two new buildings.
If the planners approve the bid, Mr Djamarani hopes to start building work soon after approval.
One of the buildings is hoped to be constructed on a brown field site at the junction of Edward Benefer Way and Bergen Way while the second unit will be put up on scrubland.
National companies who have undertaken projects in the West Norfolk area are hoped to be constructing the units, which will be made up of a steel portal frame and metal cladding.
The manufacturing units could be built and fitted out with manufacturing equipment within the next 12 to 15 months.
Mr Djamarani is keen to stress that the jobs will not be created straight away.
He said: “We would like to start as soon as possible. The aim is to get going as quickly as possible.
“The jobs won’t necessarily start straight away but there is potential for the number to go up to 200 over time.”
Earlier this year, we reported that Bespak had signed a contract for an undisclosed sum with Nicoventures to produce the inhaler.
The product has received a licence from the Medicines and Healthcare Products Regulatory Authority, which the firm says makes it different from electronic cigarette products.
Mr Djarmarani says the company has weathered the difficult economic climate thanks to the expertise of his staff.
He said: “We try to compete as strongly as we can.
“These opportunities are testament to the skills of the organisation and the effort of the people involved.”